Morgan Stanley Maintains Overweight on CRH, Lowers Price Target to $129

Benzinga · 1d ago
Morgan Stanley analyst Angel Castillo maintains CRH (NYSE:CRH) with a Overweight and lowers the price target from $139 to $129.